January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
December 22, 2024 What About Federal Reserve Rates Cut?
December 20, 2024 Honda-Nissan Alliance: A Bold Move To Dominate Auto Industry
December 13, 2024 Trump’s Plan: Potential Shake-Up For Bank Regulators
Tesla: High Hopes, Low Deliveries
Nvidia: Don’t Expect Major Gains From Here (Technical Analysis)
3M Company: Laying The Groundwork For Margin Expansion
Pop Goes The Tesla (Our Top Short For 2025)
Apple: A Piece Of This Pie Is Too Expensive For Me
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
December 21, 2024 Best Economic Calendars For Traders
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
BioNTech (BNTX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: January 18, 2025 (15:14)
Sector: HealthcareThe share price of BioNTech SE (BNTX) now
News Impact Analyzer
Full report|
This Week
|
Na | Impact: Na | News: 1 |
|
Previous Week
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
|
Two Weeks Ago
|
Na | Impact: Na | News: 2 |
|
Three Weeks Ago
|
Na | Impact: Na | News: Na |
Analyzing the Most Important BNTX news
Arbutus Eyes Windfall from Pharma's Bird Flu Vaccines
Vaccine Stocks Surge as Respiratory Illnesses Rise in the U.S.
Moderna and Merck Lead 2025 Cancer Breakthroughs
Historical and forecast chart of BioNTech stock
The chart below shows the historical price of BioNTech stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the BioNTech stock price can be found in the table below.
Long-term forecasts by years.
Comprehensive Analysis of BioNTech (BNTX) Stock Market Performance
Our multifaceted analysis of BioNTech's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in BioNTech stock?
- When should I record a loss on BioNTech stock?
- What are analysts' forecasts for BioNTech stock?
- What is the future of BioNTech stock?
We forecast BioNTech stock performance using neural networks based on historical data on BioNTech stocks.
BioNTech SE is a German biotechnology company that develops and manufactures active immunotherapeutic agents for an individual approach to the treatment of serious diseases. The company is investigating messenger RNA (mRNA) -based drugs for use as individualized immunotherapy for cancer, as vaccines against infectious diseases and as protein replacement therapy for rare diseases, as well as developed cell therapy, new antibodies and small molecules, immunomodulators, as options cancer treatment. The company has developed an intravenous mRNA-based human therapeutic drug to bring individualized mRNA-based cancer immunotherapy to clinical trials and establish its own manufacturing process.
BioNTech SE News influencing stock rates
As of now, Panda has combed through 4 news items directly related to BNTX from the last 30 days. Out of these, 1 clearly showcase a bullish trend, while 0 display bearish tendencies, and 3 events are neutral.
Based on an analysis of the most important news from the last 30 days affecting BNTX shares, it's clear that bullish sentiments are completely overshadowing bearish ones. The impact of positive news is more than five times as dominant as that of negative developments.
The news analyzed fell within the period from Dec 27, 2024, to Jan 07, 2025.
BioNTech Settles $1B Royalty Claims with NIH and University of Pennsylvania
Trump Picks Bhattacharya to Lead NIH Amid Health Policy Shakeup
CDC Warns of Holiday Virus Surge: Vaccine Stocks in Focus
BioNTech Rated as Strong Buy Amid Promising Oncology Future
Vaccine Stocks Plummet Amid RFK Jr. HHS Concerns
RFK's Appointment Sparks Vaccine Market Jitters
Vaccine Stocks Stumble on RFK Jr. HHS Nomination News
Merck's $3.3B Play: Securing Global Rights to Chinese Cancer Drug
BioNTech Expands Oncology Footprint with $950M Biotheus Acquisition
BioNTech Gains Momentum with Promising Tumor Therapy
BioNTech daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan 20 | 117.82 | 112.94 | 122.49 | 8.45 |
| Jan 21 | 115.63 | 114.17 | 117.64 | 3.04 |
| Jan 22 | 114.38 | 111.77 | 115.89 | 3.68 |
| Jan 23 | 109.51 | 106.49 | 114.76 | 7.77 |
| Jan 24 | 110.89 | 106.90 | 115.81 | 8.34 |
| Jan 25 | 112.68 | 107.41 | 117.21 | 9.13 |
| Jan 26 | 111.06 | 106.26 | 113.39 | 6.71 |
| Jan 27 | 112.59 | 108.54 | 116.72 | 7.53 |
| Jan 28 | 108.81 | 105.29 | 111.03 | 5.46 |
| Jan 29 | 111.81 | 107.99 | 113.42 | 5.03 |
| Jan 30 | 110.20 | 105.38 | 114.90 | 9.04 |
| Jan 31 | 114.90 | 111.80 | 117.11 | 4.75 |
| Feb 01 | 113.59 | 111.89 | 118.70 | 6.09 |
| Feb 02 | 113.59 | 111.27 | 117.07 | 5.21 |
| Feb 03 | 111.27 | 106.60 | 114.54 | 7.45 |
| Feb 04 | 114.21 | 112.36 | 118.18 | 5.18 |
| Feb 05 | 116.88 | 111.48 | 121.16 | 8.68 |
| Feb 06 | 118.64 | 114.93 | 123.19 | 7.18 |
| Feb 07 | 118.99 | 117.56 | 124.42 | 5.83 |
| Feb 08 | 117.63 | 115.31 | 122.08 | 5.88 |
| Feb 09 | 114.25 | 109.45 | 117.88 | 7.70 |
| Feb 10 | 117.26 | 114.38 | 119.09 | 4.12 |
| Feb 11 | 123.24 | 118.44 | 128.86 | 8.80 |
| Feb 12 | 119.62 | 113.95 | 123.35 | 8.25 |
| Feb 13 | 123.50 | 118.61 | 127.05 | 7.12 |
| Feb 14 | 127.20 | 122.93 | 133.15 | 8.32 |
| Feb 15 | 128.96 | 125.63 | 134.76 | 7.27 |
| Feb 16 | 132.36 | 126.56 | 138.00 | 9.04 |
| Feb 17 | 134.98 | 130.04 | 139.19 | 7.04 |
| Feb 18 | 129.15 | 123.80 | 135.12 | 9.14 |
BioNTech Daily Price Targets
BioNTech Stock Forecast 01-20-2025.
Forecast target price for 01-20-2025: $117.82.
Positive dynamics for BioNTech shares will prevail with possible volatility of 7.791%.
Pessimistic target level: 112.94
Optimistic target level: 122.49
BioNTech Stock Forecast 01-21-2025.
Forecast target price for 01-21-2025: $115.63.
Negative dynamics for BioNTech shares will prevail with possible volatility of 2.949%.
Pessimistic target level: 114.17
Optimistic target level: 117.64
BioNTech Stock Forecast 01-22-2025.
Forecast target price for 01-22-2025: $114.38.
Negative dynamics for BioNTech shares will prevail with possible volatility of 3.553%.
Pessimistic target level: 111.77
Optimistic target level: 115.89
BioNTech Stock Forecast 01-23-2025.
Forecast target price for 01-23-2025: $109.51.
Negative dynamics for BioNTech shares will prevail with possible volatility of 7.214%.
Pessimistic target level: 106.49
Optimistic target level: 114.76
BioNTech Stock Forecast 01-24-2025.
Forecast target price for 01-24-2025: $110.89.
Positive dynamics for BioNTech shares will prevail with possible volatility of 7.698%.
Pessimistic target level: 106.90
Optimistic target level: 115.81
BioNTech Stock Forecast 01-25-2025.
Forecast target price for 01-25-2025: $112.68.
Positive dynamics for BioNTech shares will prevail with possible volatility of 8.364%.
Pessimistic target level: 107.41
Optimistic target level: 117.21
BNTX (BNTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb. | 121.06 | 110.02 | 128.18 | 14.17 |
| Mar. | 114.38 | 109.99 | 123.71 | 11.09 |
| Apr. | 114.52 | 104.35 | 117.95 | 11.53 |
| May. | 105.59 | 102.93 | 108.75 | 5.36 |
| Jun. | 110.91 | 102.66 | 116.23 | 11.68 |
| Jul. | 118.89 | 115.18 | 127.74 | 9.83 |
| Aug. | 116.75 | 110.17 | 120.54 | 8.60 |
| Sep. | 117.59 | 110.40 | 124.51 | 11.33 |
| Oct. | 112.80 | 103.86 | 118.35 | 12.24 |
| Nov. | 108.74 | 99.08 | 118.26 | 16.22 |
| Dec. | 110.82 | 105.64 | 119.47 | 11.58 |
BioNTech forecast for this year
BioNTech Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $121.063. Pessimistic: $110.02. Optimistic: $128.18
BioNTech Stock Prediction for Mar 2025
An downtrend is forecast for this month with an optimal target price of $114.381. Pessimistic: $109.99. Optimistic: $123.71
BioNTech Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $114.518. Pessimistic: $104.35. Optimistic: $117.95
BioNTech Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $105.586. Pessimistic: $102.93. Optimistic: $108.75
BioNTech Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $110.907. Pessimistic: $102.66. Optimistic: $116.23
BioNTech Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $118.892. Pessimistic: $115.18. Optimistic: $127.74
BioNTech Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $116.752. Pessimistic: $110.17. Optimistic: $120.54
BioNTech Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $117.593. Pessimistic: $110.40. Optimistic: $124.51
BioNTech Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $112.795. Pessimistic: $103.86. Optimistic: $118.35
BioNTech Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $108.735. Pessimistic: $99.08. Optimistic: $118.26
BioNTech Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $110.822. Pessimistic: $105.64. Optimistic: $119.47
BioNTech (BNTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 115.08 | 104.03 | 118.94 | 12.54 |
| Feb | 109.14 | 103.38 | 113.07 | 8.57 |
| Mar | 105.60 | 96.61 | 109.15 | 11.49 |
| Apr | 117.26 | 107.98 | 121.48 | 11.12 |
| May | 113.04 | 108.29 | 123.76 | 12.50 |
| Jun | 113.18 | 108.97 | 121.33 | 10.19 |
| Jul | 106.39 | 99.24 | 113.02 | 12.20 |
| Aug | 100.13 | 92.32 | 104.70 | 11.82 |
| Sep | 93.76 | 87.46 | 99.95 | 12.50 |
| Oct | 98.15 | 95.21 | 101.92 | 6.59 |
| Nov | 96.38 | 91.76 | 98.81 | 7.14 |
| Dec | 85.28 | 79.04 | 87.84 | 10.02 |
BioNTech (BNTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 88.25 | 83.27 | 91.95 | 9.44 |
| Feb | 86.66 | 81.04 | 92.59 | 12.47 |
| Mar | 93.11 | 87.07 | 98.58 | 11.67 |
| Apr | 98.47 | 95.75 | 104.50 | 8.37 |
| May | 98.82 | 96.22 | 104.99 | 8.36 |
| Jun | 100.49 | 98.07 | 107.24 | 8.55 |
| Jul | 106.27 | 100.66 | 110.48 | 8.89 |
| Aug | 103.72 | 98.12 | 108.33 | 9.42 |
| Sep | 113.93 | 110.51 | 122.95 | 10.12 |
| Oct | 111.88 | 102.35 | 121.68 | 15.89 |
| Nov | 113.76 | 104.34 | 122.49 | 14.82 |
| Dec | 110.89 | 103.17 | 119.94 | 13.98 |
BioNTech information and performance
AN DER GOLDGRUBE 12, MAINZ, DE
Market capitalization of the BioNTech SE is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BNTX shares in the company outstanding by the market price of one share.
EBITDA of BioNTech is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
BioNTech (BNTX) stock dividend
BioNTech last paid dividends on 06/02/2022. The next scheduled payment will be on 06/17/2022. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
